“Second-Generation Androgen Receptor Inhibitors in Therapy of Non-Metastatic Castration Resistant Prostate Cancer: Role of Safety Profile and Effect on Quality of Life”. Voprosy Onkologii, vol. 67, no. 2, May 2022, pp. 217-26, https://doi.org/10.37469/0507-3758-2021-67-2-217-226.